Shaker A. Mousa

Comparison of the effect of different platelet GPIIb/IIa antagonists on the dynamics of platelet/fibrin-mediated clot strength induced using thromboelastography.

S. Mousa, M. Forsythe, Shaker A. Mousa, 2001, Thrombosis research.

Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists.

S. Mousa, M. Forsythe, S. Khurana, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Platelet GPIIb/IIIa receptor occupancy studies using a novel fluoresceinated cyclic Arg-Gly-Asp peptide.

S. Mousa, S. Jackson, J. Bozarth, 1995, Thrombosis research.

Glycoprotein IIb/IIIa receptor antagonists inhibit the development of platelet procoagulant activity.

S. Mousa, D. Pedicord, I. Dicker, 1998, Thrombosis research.

Effect of single oral dose of aspirin on human platelet functions and plasma plasminogen activator inhibitor-1.

S. Mousa, J. Bozarth, M. Forsythe, 1993, Cardiology.

Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist.

W. DeGrado, S. Mousa, B. Lucchesi, 1996, Circulation.